401 – 410 of 554
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Cognitive and functional changes associated with Aβ pathology and the progression to mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
External validation of a 3-step falls prediction model in mild Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
(
- Contribution to journal › Article
-
Mark
White matter lesions highly influence group comparison of diffusion tensor imaging metrics
2016) ISMRM, 2016(
- Contribution to conference › Poster
- 2015
-
Mark
β-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease.
(
- Contribution to journal › Scientific review
-
Mark
CSF biomarkers and clinical progression of Parkinson disease.
(
- Contribution to journal › Article
-
Mark
Disease-specific structural changes in thalamus and dentatorubrothalamic tract in progressive supranuclear palsy.
(
- Contribution to journal › Article
-
Mark
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Spatial navigation measured by the Floor Maze Test in patients with subjective cognitive impairment, mild cognitive impairment, and mild Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.
(
- Contribution to journal › Article